NT$ 71.4
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Solid dividends
Data is available to registered users only
Data is available to registered users only
About
A Plus Biotechnology Co., Ltd. engages in the research, development, manufacture, and sales of orthopedic medical equipment. Its products include implants, plates, and screw systems, which are primarily designed to match the anatomy of Asian patients.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overvalued on P/FCF.
Data is available to registered users only